Author:
Gibson B E S, ,Wheatley K,Hann I M,Stevens R F,Webb D,Hills R K,De Graaf S S N,Harrison C J
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference23 articles.
1. Rees JKH, Gray RG, Swirsky D, Hayhoe FGJ, for the Medical Research Council's Working Parties for Therapeutic Trials in Adult and Childhood Leukaemia. Principal results of the Medical Research Council's 8th Acute Myeloid Leukaemia Trial. Lancet 1986; ii: 1236–1241.
2. Marcus RE, Catovsky D, Prentice HG, Newland AC, Chessells JM, Stevens RM et al. Intensive Induction and Consolidation Chemotherapy for Adults and Children with Acute Myeloid Leukaemia (AML) Joint AML Trial 1982–1985. In: Büchner Th, Schellong G, Hiddemann W, Urbanitz D, Ritter J, (eds). Acute Leukaemias. Prognostic Factors and Treatment Strategies, Haematology and Blood Transfusion, Vol. 30. Berlin-Heidelberg-New York, Tokyo: Springer-Verlag, 1987.
3. Rees JKH, Gray RG, Wheatley K, on behalf of the MRC Leukaemia in Adults Working Party. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. Br J Haematol 1996; 94: 89–98.
4. Worsley AM, Catovsky D, Goldman JM, Galton DAG . New combination chemotherapy for relapsed acute myeloid leukaemia. Lancet 1984; I: 1232.
5. Preisler H . High-dose Ara-C as the initial treatment of poor risk patients with acute non-lymphocytic leukaemia. A leukaemia intergroup study. J Am Soc Clin Oncol 1987; 5: 75–82.
Cited by
238 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献